PDL BIOPHARMA, INC. 4/A SEC Filings

Filed On	Filing
07 Apr 2020	Form 4/A: Imbrogno Edward, VP Finance, CAO and Acting CFO Received 292,208 shares as a grant or award
07 Apr 2020	Form 4/A: Monnet Dominique, President and CEO Received 1,233,766 shares as a grant or award
07 Apr 2020	Form 4/A: Jene Jill M., VP, Business Development Received 194,805 shares as a grant or award
07 Apr 2020	Form 4/A: Stone Christopher Lewis, VP, Gen. Counsel & Secretary Received 422,078 shares as a grant or award
16 Apr 2019	Form 4/A: Jene Jill M., VP, Business Development Granted 384,615 Stock Option (right to buy)
16 Apr 2019	Form 4/A: Stone Christopher Lewis, VP, Gen. Counsel & Secretary Granted 833,333 Stock Option (right to buy)
16 Apr 2019	Form 4/A: Garcia Peter S, Vice President, CFO Granted 641,025 Stock Option (right to buy)
16 Apr 2019	Form 4/A: Monnet Dominique, President and CEO Received 451,075 shares as a grant or award ($1.68M) · Granted 2,450,000 Stock Option (right to buy)
28 Jan 2016	Form 4/A: Stone Christopher Lewis, VP, Gen. Counsel & Secretary Received 30,693 shares as a grant or award ($252K)
17 Apr 2009	Form 4/A: Mclaughlin John Peter, Director Granted 3,500 Stock Option (Right to Buy)
13 Apr 2009	Form 4/A: Sandman Paul W, Director Bought 10,000 shares ($73.8K)
15 Jul 2005	Form 4/A: Mcdade Mark, Director Received 0 shares by exercise or conversion (—) · Sold 0 shares (—)
11 Jul 2005	Form 4/A: Korn Laurence Jay, Director Received 0 shares by exercise or conversion (—) · Sold 0 shares (—)
11 Jul 2005	Form 4/A: Korn Laurence Jay, Director Disposed of 0 Stock Option (right to buy) (Disposition to Issuer) · Granted 0 Stock Option (right to buy)
29 Jun 2005	Form 4/A: Saxe Jon S, Director Granted 0 Stock Option (right to buy)
27 Jun 2005	Form 4/A: Queen Cary L, Director Received 0 shares by exercise or conversion (—) · Sold 0 shares (—)
27 Jun 2005	Form 4/A: Link Max, Director Granted 0 Stock Option (right to buy)
27 Jun 2005	Form 4/A: Gage L Patrick, Director Granted 0 Stock Option (right to buy)
27 Jun 2005	Form 4/A: Dawes Karen A, Director Received 0 shares by exercise or conversion (—)
01 Mar 2005	Form 4/A: Queen Cary L, Director Sold 20,000 shares ($409K)

Comments